Gardner Lewis Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Gardner Lewis Asset Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-112,500	Closed	-$7.66M	–	99
2022 Q3	$7.66M	Buy	+112,500	New	+$6.2M	1.69%	20

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gardner Lewis Asset Management's GBT Position: Q4 2022 in Review

Gardner Lewis Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 112,500 shares — an estimated $7.66M sold.

Gardner Lewis Asset Management first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $7.66M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Gardner Lewis Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Gardner Lewis Asset Management sold 112,500 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $7.66M.
Gardner Lewis Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
Gardner Lewis Asset Management's Global Blood Therapeutics, Inc. position peaked at $7.66M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Gardner Lewis Asset Management's 13F filing for Q4 2022, filed 10 Feb 2023.